Omega Healthcare Investors (OHI) Q3 2025 Earnings
How Did OHI Stock React to Q3 2025 Earnings?
S&P 500 over the same 30 days: +0.27%.
Did OHI Beat Earnings? Q3 2025 Results
Yes. Omega Healthcare Investors reported Q3 2025 earnings of $0.59 a share on Oct 30, 2025, beating the $0.45 consensus estimate by 30.9%. Revenue was $311.6M against a $261.6M estimate.
Omega Healthcare Investors delivered a standout third quarter, posting earnings per share of $0.59 against a consensus estimate of $0.45, a beat of nearly 31%, while revenue of $311.59 million cleared Wall Street's $261.59 million forecast by 19.11% and climbed 12.9% from a year ago. The primary engine behind the results was a surge in rental income to $260.74 million from $227.77 million in Q3 2024, reflecting the skilled nursing REIT's aggressive investment pace, which reached $756.02 million year-to-date through September. A headline post-quarter development reinforced the growth trajectory: Omega formed a joint venture with Saber Healthcare, acquiring a 49% equity stake in 64 facilities generating $69.40 million in annual contractual rent, a deal that signals the company's expanding appetite for complex partnership structures. Adjusted FFO rose to $0.79 per diluted share from $0.74 a year ago, and management lifted full-year 2025 AFFO guidance to $3.08 to $3.10 per share, up from both the prior range of $3.04 to $3.07 and the initial outlook of $2.90 to $2.98.
- Rental income growth driven by $978 million in new investments year-to-date
- Improving operator occupancy reaching 82.6% for twelve months ended June 30, 2025
- EBITDARM coverage improvement to 1.91x before management fees
- Gain on asset sales of $28.2 million from sale of 11 facilities
- Increased real estate loan interest income to $34.4 million from $33.6 million in Q3 2024
- Higher other income of $16.8 million vs. a loss of $1.0 million in Q3 2024
“We again delivered strong quarterly results, as we continue to grow FAD per share while further de-levering the balance sheet. We have accretively invested nearly $1 billion year-to-date and, as a result, we are increasing our 2025 AFFO guidance again to now be between $3.08 and $3.10 per share, up from our initial guidance range of between $2.90 and $2.98 per share.”
Omega Healthcare Investors CEO, on the earnings call
What Was Omega Healthcare Investors's Outlook in Q3 2025?
Omega increased its full year 2025 Adjusted FFO guidance to $3.08–$3.10 per diluted share, up from the prior range of $3.04–$3.07 and well above the initial guidance of $2.90–$2.98. The revised guidance incorporates $756 million in new investments completed year-to-date through September 2025 and the $222 million Saber JV investment. Key assumptions include: Genesis continues full contractual payments, Maplewood continues rent at $6.3 million per month, Q4 G&A expense of $13.5–$14.5 million, repayment of $245.9 million GBP secured mortgage in November 2025 via the delayed draw term loan, approximately $56 million of maturing mortgages converting to fee simple real estate with the balance extended beyond 2025, and approximately $15 million in asset sales. The guidance excludes additional acquisitions, capital markets activity, and additional credit loss provisions.
OHI YoY Financials
| Metric | Q3 2025 | Q3 2024 | Year over year |
|---|---|---|---|
| Revenue | $311.6M | $276.0M | +12.9% |
| Net Income | $185.0M | $111.8M | +65.5% |
| Operating Income | $191.3M | $182.5M | +4.8% |
OHI Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.